Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Carla
Carla is an MD/PhD candidate in the Health Sciences and Technology program at Harvard-MIT. She earned her BS in Bioengineering from UPenn and her MS in Regenerative Medicine from the National University of Ireland.
Elliot
Elliot earned his BS in Biology at MIT, and his MSc by Research in Clinical Medicine on a Rhodes Scholarshop at Oxford University. Currently, he is an MD/PhD student in the the Harvard-MIT Health Sciences and Technology program.